FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000338552> ?p ?o ?g. }

• W2000338552 endingPage "19" @default.
• W2000338552 startingPage "10" @default.
• W2000338552 abstract "A total of 125 children, who were diagnosed as having high-risk acute lymphoblastic leukemia (ALL), were treated with two consecutive protocols designated as AL851 (1985-1988) and ALHR88 (1988-1990). All patients received induction therapy consisting of vincristine (VCR), prednisolone (PSL), daunorubicin (DNR), and I-asparaginase (I-Asp). In the ALHR88 protocol, the patients whose blasts in the bone marrow (BM) were > or = 25% on day 14 of induction therapy and who were classified into T-cell type received additional cytosine arabinoside (AraC). After consolidation with intermediate-dose methotrexate (MTX), reinduction therapy including VCR, dexamethasone, and adriamycin followed by high-dose AraC was done for all patients. Intrathecal MTX and 24Gy of cranial irradiation were used to prevent central nervous system leukemia. A maintenance therapy consisting of 6-mercaptopurine, cyclophosphamide, MTX, DNR, VCR, and AraC was administered for 3 years after achieving a complete remission (CR). CR was achieved in 51/55 (92.7%) for AL851 and 68/70 (97.1%) for ALHR88. The 5-year event-free survival rates were 49.1 +/- 6.7% in AL851 and 62.5 +/- 6.1% in ALHR88. The factors related to a poor prognosis were a high initial leukocyte count of greater than 50 x 10(9)/L (P < 0.001), an L2 morphology of leukemic cells by FAB classification (P = 0.009), the chromosomal abnormality (P = 0.004) and high residual leukemic cells in BM (> or = 25%) on day 14 of induction therapy (P < 0.001). Taking these factors into consideration, more intensive protocols were started in 1990 for the patients with high-risk ALL." @default.
• W2000338552 created "2016-06-24" @default.
• W2000338552 creator A5018156887 @default.
• W2000338552 creator A5018989227 @default.
• W2000338552 creator A5021236377 @default.
• W2000338552 creator A5023045448 @default.
• W2000338552 creator A5023572058 @default.
• W2000338552 creator A5025500636 @default.
• W2000338552 creator A5028856515 @default.
• W2000338552 creator A5044063280 @default.
• W2000338552 creator A5044535765 @default.
• W2000338552 creator A5045256843 @default.
• W2000338552 creator A5057488415 @default.
• W2000338552 creator A5066965561 @default.
• W2000338552 creator A5080937389 @default.
• W2000338552 creator A5083776718 @default.
• W2000338552 creator A5083964550 @default.
• W2000338552 date "1996-01-01" @default.
• W2000338552 modified "2023-10-09" @default.
• W2000338552 title "Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: A report from the Kyushu-Yamaguchi children cancer study group in Japan" @default.
• W2000338552 cites W1903488342 @default.
• W2000338552 cites W1984522634 @default.
• W2000338552 cites W2031807032 @default.
• W2000338552 cites W2034175508 @default.
• W2000338552 cites W2040103994 @default.
• W2000338552 cites W2044524439 @default.
• W2000338552 cites W2053215802 @default.
• W2000338552 cites W2064805294 @default.
• W2000338552 cites W206881734 @default.
• W2000338552 cites W2072502760 @default.
• W2000338552 cites W2095569120 @default.
• W2000338552 cites W2138205116 @default.
• W2000338552 cites W2151094076 @default.
• W2000338552 cites W2226233012 @default.
• W2000338552 cites W2336990540 @default.
• W2000338552 cites W349022134 @default.
• W2000338552 cites W4251799202 @default.
• W2000338552 cites W4293241248 @default.
• W2000338552 doi "https://doi.org/10.1002/(sici)1096-911x(199601)26:1<10::aid-mpo2>3.0.co;2-y" @default.
• W2000338552 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7494507" @default.
• W2000338552 hasPublicationYear "1996" @default.
• W2000338552 type Work @default.
• W2000338552 sameAs 2000338552 @default.
• W2000338552 citedByCount "12" @default.
• W2000338552 countsByYear W20003385522014 @default.
• W2000338552 crossrefType "journal-article" @default.
• W2000338552 hasAuthorship W2000338552A5018156887 @default.
• W2000338552 hasAuthorship W2000338552A5018989227 @default.
• W2000338552 hasAuthorship W2000338552A5021236377 @default.
• W2000338552 hasAuthorship W2000338552A5023045448 @default.
• W2000338552 hasAuthorship W2000338552A5023572058 @default.
• W2000338552 hasAuthorship W2000338552A5025500636 @default.
• W2000338552 hasAuthorship W2000338552A5028856515 @default.
• W2000338552 hasAuthorship W2000338552A5044063280 @default.
• W2000338552 hasAuthorship W2000338552A5044535765 @default.
• W2000338552 hasAuthorship W2000338552A5045256843 @default.
• W2000338552 hasAuthorship W2000338552A5057488415 @default.
• W2000338552 hasAuthorship W2000338552A5066965561 @default.
• W2000338552 hasAuthorship W2000338552A5080937389 @default.
• W2000338552 hasAuthorship W2000338552A5083776718 @default.
• W2000338552 hasAuthorship W2000338552A5083964550 @default.
• W2000338552 hasConcept C126322002 @default.
• W2000338552 hasConcept C141071460 @default.
• W2000338552 hasConcept C2776694085 @default.
• W2000338552 hasConcept C2776715498 @default.
• W2000338552 hasConcept C2776755627 @default.
• W2000338552 hasConcept C2778041864 @default.
• W2000338552 hasConcept C2778283404 @default.
• W2000338552 hasConcept C2778461978 @default.
• W2000338552 hasConcept C2778720950 @default.
• W2000338552 hasConcept C2778904437 @default.
• W2000338552 hasConcept C2779429289 @default.
• W2000338552 hasConcept C2780007613 @default.
• W2000338552 hasConcept C2780401358 @default.
• W2000338552 hasConcept C2781021840 @default.
• W2000338552 hasConcept C2781059491 @default.
• W2000338552 hasConcept C2781107101 @default.
• W2000338552 hasConcept C2909962599 @default.
• W2000338552 hasConcept C71924100 @default.
• W2000338552 hasConcept C90924648 @default.
• W2000338552 hasConceptScore W2000338552C126322002 @default.
• W2000338552 hasConceptScore W2000338552C141071460 @default.
• W2000338552 hasConceptScore W2000338552C2776694085 @default.
• W2000338552 hasConceptScore W2000338552C2776715498 @default.
• W2000338552 hasConceptScore W2000338552C2776755627 @default.
• W2000338552 hasConceptScore W2000338552C2778041864 @default.
• W2000338552 hasConceptScore W2000338552C2778283404 @default.
• W2000338552 hasConceptScore W2000338552C2778461978 @default.
• W2000338552 hasConceptScore W2000338552C2778720950 @default.
• W2000338552 hasConceptScore W2000338552C2778904437 @default.
• W2000338552 hasConceptScore W2000338552C2779429289 @default.
• W2000338552 hasConceptScore W2000338552C2780007613 @default.
• W2000338552 hasConceptScore W2000338552C2780401358 @default.
• W2000338552 hasConceptScore W2000338552C2781021840 @default.
• W2000338552 hasConceptScore W2000338552C2781059491 @default.
• W2000338552 hasConceptScore W2000338552C2781107101 @default.
• W2000338552 hasConceptScore W2000338552C2909962599 @default.
• W2000338552 hasConceptScore W2000338552C71924100 @default.

• next